Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls

Occupational and Environmental Medicine

Volumn 53, Issue 11, 1996, Pages 736-740

  Schütz, Andrejs ^a   Bergdahl, Ingvar A ^a   Ekholm, Anders ^a   Skerfving, Staffan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ICP MS; Lead; Plasma

Indexed keywords

LEAD;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LEAD POISONING; MALE; MASS SPECTROMETRY; METAL INDUSTRY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SWEDEN;

EID: 0029798991     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.53.11.736     Document Type: Article

References (46)

1. Manton WI, Cook JD. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Br J Ind Med 1984;41:313-9.
2. Clarkson TW, Kench JE. Uptake of lead by human erythrocytes in vitro. Biochemistry 1958;69:432-9.
3. Campbell BC, Meredith PA, Moore MA, Watson WS. Kinetics of lead following intravenous administration in man. Toxicol Lett 1984;21:231-5.
4. Barton JC. Retention of radiolead by human erythrocytes in vitro. Toxicol Appl Pharmacol 1989;99:314-22.
5. Simons T. Lead transport and binding by human erythrocytes in vitro. Pflugers Arch 1993;423:307-13.
6. Moore MR. Haematological effects of lead. Sci Total Environ 1988;71:419-31.
7. Al-Modhefer AJA, Bradbury MWB, Simons TJB. Observations on the chemical nature of lead in human blood serum. Clin Sci 1991;81:823-9.
8. Everson J, Patterson CC. "Ultra-clean" isotope dilution mass spectrometric analyses for lead in human blood plasma indicate that most reported values are artificially high. Clin Chem 1980;26:1603-7.
9. Copeland TR, Christie JH, Osteryoung RA, Skogerboe RK. Analytical applications of pulsed voltammetric stripping at thin film mercury electrodes. Anal Chem 1973; 45:2171-4.
10. Rosen JF, Zarate-Salvador C, Trinidad EE. Plasma lead levels in lead-intoxicated children. J Pediatr 1974;84: 45-8.
11. Baloh RW, Spivey GH, Brown CP, Morgan D, Campion DS, Browdy BI, et al. Subclinical effects of chronic increased lead absorption a prospective study. J Occup Med 1979;21:490-6.
12. Araki S, Aono H, Murata K. Mobilization of heavy metals into the urine by Ca- EDTA: relation to erythrocyte and plasma concentrations and exposure indicators. Br J Ind Med 1986;43:636-41.
13. Ong CN, Phoon WO, Lee BL, Lim LE, Chua LH. Lead in plasma and its relationships to other biological indicators. Ann Occup Hyg 1986;30:219-28.
14. Cavalleri A, Minoia C, Pozzoli L, Baruffini A. Determination of plasma lead levels in normal subjects and in lead-exposed workers. Br J Ind Med 1978;35: 21-6.
15. Desilva PE. Determination of lead in plasma and studies on its relationship to lead in erythrocytes. Br J Ind Med 1981;38:209-17.
16. Williams MK, King E, Walford J. An investigation of lead absorption in an electric accumulator factory with use of personal samplers. Br J Ind Med 1969;26:202-16.
17. Azar A, Snee RD, Habibi K. Lead. An epidemiological approach to community air lead exposure using personal air samples. Environmental Quality and Safety 1975; (suppl II):152-96.
18. Chamberlain AC. Effect of airborne lead on blood lead. Atmospheric Environment 1983;17:677-92.
19. UK Royal Commission on Environmental Pollution. Lead in the environment. Her Majesty's Stationery Office, London, 1983:176. (9th report No 8852.)
20. Brunekreef B. The relationship between air lead and blood lead in children. Sci Tot Environ 1984;38:79-123.
21. Laxen DPH, Raab GM, Fulton M. Children's blood lead and exposure to lead in household dust and water - a basis for an environmental standard for lead in dust. Sci Total Environ 1987;66:235-44.
22. Hodgkins DG, Hinkamp DL, Robins TG, Levine SP, Schork MA, Krebs WH. Air-lead particle sizes in battery manufacturing: potential effects on the OSHA compliance model. Appl Occup Environ Hyg 1990;5:518-25.
23. Schütz A, Skerfving S. Effect of a short, heavy exposure to lead dust upon lead level, erythrocyte δ-aminolevulinic acid dehydratase activity and urinary excretion of lead, δ-aminolevulinic acid, and coproporphyrine. Scand J Work Environ Health 1976;3:176-84.
24. Piomelli S. A micromethod for free erythrocyte porphyrines: the FEP test. J Lab Clin Med 1973;81:932-40.
25. Tola S, Hernberg S, Asp S, Nikkanen J. Parameters indicative of absorption and biological effect in new lead exposure: a prospective study. Br J Ind Med 1973; 30:134-41.
26. Baloh RW. Laboratory diagnosis of increased lead absorption. Arch Environ Health 1974;28:198-208.
27. Allesio L, Bertazzi PA, Monelli O, Foa V. Free erythrocyte protoporphyrin as an indicator of the biological effect of lead in adult males. Int Arch Occup Environ Health 1976; 37:89-105.
28. Joselow MM, Flores J. Application of the zinc protoporphyrin (ZP) test as a monitor of occupational exposure to lead. Am Iud Hyg Assoc J 1977;38:63-6.
29. Haeger-Aronsen B, Schütz A. Zink protoporphyrin in blood a new method for assessment of the influence of lead. Läkartidningen 1978;75:3427-30.
30. Chamberlain MJ, Massey PMO. Mild lead poisoning with an excessively high blood lead. Br J Ind Med 1972; 29:458-61.
31. Torkington P, Bhalla KK. Lead poisoning with low blood lead levels. Postgrad Med J 1974;50:240-2.
32. Lilis R, Fischbein A, Eisinger J, Blumberg WE, Diamond S, Anderson HA, et al. Prevalence of lead disease among secondary lead smelter workers and biological indicators of lead exposure. Environ Res 1977;14:255-85.
33. Lilis R, Valciukas J, Fischbein A, Andrews G, Selikoff IJ, Blumberg W. Renal function impairment in secondary lead smelter workers: correlations with zinc protoporphyrin and blood lead levels. J Environ Pathol Toxicol 1979;2:1447-74.
34. Lutz TM, Nirel PMV, Schmidt B. Whole blood analysis by ICP-MS. In: Holland G, Eaton AN, eds. Applications of plasma source mass spectrometry. Cambridge, UK: The Royal Society of Chemistry, 1991:96-100.
35. Mauras Y, Premet-Cabic A, Berre S, Allain P. Simultaneous determination of lead, bismuth, and thallium in plasma and urine by inductively coupled plasma mass spectrometry. Clin Chim Acta 1993;218:201-5.
36. Conradi S, Ronnevi LO, Vesterberg O. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurg Psychiatry 1978;41:389-93.
37. Conradi S, Ronnevi LO, Nise G, Vesterberg O. Long-time penicillamine-treatment in amyotrophic lateral sclerosis with parallel determination of lead in blood, plasma, and urine. Acta Neurol Scand 1982;65:203-11.
38. Ronnevi LO, Conradi S, Nise G. Further studies on the uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. J Neurol Sci 1982;57: 143-56.
39. Ishihara N, Shiojima S, Hasegawa K. Lead and zinc concentrations in plasma, erythrocytes, and urine in relation to ALA-D activity after intravenous infusion of Ca-EDTA. Br J Ind Med 1984;41:235-40.
40. 1 levels of lead in human plasma. Journal of Analytical Atomic Spectrometry 1994;9:1233-6.
41. Manton WI, Malloy CR. Distribution of lead in body fluids after ingestion of soft solder. Br J Ind Med 1983;40:51-7.
42. 212Pb from the gastrointestinal tract of man. Acta Radiologica Therapy Physics Biology 1968;7:108-20.
43. Sakai T, Yanagihara S, Kunugi Y, Ushio K. Relationship between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D. Br J Ind Med 1982;39: 382-7.
44. Bergdahl IA, Schütz A, Grubb A. Application of liquid chromatography inductively coupled plasma mass spectrometry to the study of protein-bound lead in human erythrocytes. Journal of Analysis of Atomic Spectrometry 1966 (in press).
45. Raghavan SRV, Culver BD, Gonick HC. Erythrocyte lead-binding protein after occupational exposure. I. Relationship to lead toxicity. Environ Res 1980;22: 264-70.
46. Lolin Y, O'Gorman P. An intra-erythrocytic low molecular weight lead-binding protein in acute and chronic lead exposure and its possible protective role in lead toxicity. Ann Clin Biochem 1988;25:688-97.